Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodentine and Simvastatin for Pulpotomy in Primary Molars
NCT05582317Completed
- Sponsor
- Suez Canal University
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, single-blind trial of simvastatin and Biodentine in pulpitis, sponsored by Suez Canal University. Primary endpoint: Clinical Success Rate at 12 months. Started May 2021; status: completed.
02
Drugs
simvastatinBiodentine
03
Conditions
pulpitis
Beyond the preview
Go deeper on NCT05582317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05582317.